A detailed history of New York State Common Retirement Fund transactions in Catalent, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 108,330 shares of CTLT stock, worth $6.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
108,330
Previous 121,430 10.79%
Holding current value
$6.38 Million
Previous $6.83 Million 3.9%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$56.16 - $60.96 $735,696 - $798,576
-13,100 Reduced 10.79%
108,330 $6.56 Million
Q2 2024

Jul 31, 2024

SELL
$53.58 - $57.02 $13.1 Million - $13.9 Million
-243,680 Reduced 66.74%
121,430 $6.83 Million
Q1 2024

May 07, 2024

SELL
$42.56 - $59.82 $5.27 Million - $7.41 Million
-123,855 Reduced 25.33%
365,110 $20.6 Million
Q4 2023

Feb 01, 2024

SELL
$32.18 - $46.57 $732,159 - $1.06 Million
-22,752 Reduced 4.45%
488,965 $22 Million
Q3 2023

Nov 07, 2023

BUY
$44.2 - $50.2 $537,251 - $610,181
12,155 Added 2.43%
511,717 $23.3 Million
Q2 2023

Aug 07, 2023

SELL
$31.86 - $67.26 $3.42 Million - $7.22 Million
-107,385 Reduced 17.69%
499,562 $21.7 Million
Q1 2023

May 02, 2023

SELL
$45.44 - $74.26 $10.5 Million - $17.2 Million
-232,129 Reduced 27.66%
606,947 $39.9 Million
Q4 2022

Jan 30, 2023

BUY
$41.39 - $81.0 $13.3 Million - $26.1 Million
321,639 Added 62.16%
839,076 $37.8 Million
Q3 2022

Nov 08, 2022

SELL
$72.36 - $113.1 $386,836 - $604,632
-5,346 Reduced 1.02%
517,437 $37.4 Million
Q2 2022

Aug 04, 2022

SELL
$87.2 - $114.05 $792,037 - $1.04 Million
-9,083 Reduced 1.71%
522,783 $56.1 Million
Q1 2022

May 05, 2022

SELL
$94.19 - $124.49 $310,356 - $410,194
-3,295 Reduced 0.62%
531,866 $59 Million
Q4 2021

Feb 02, 2022

SELL
$119.57 - $139.07 $17.3 Million - $20.1 Million
-144,614 Reduced 21.27%
535,161 $68.5 Million
Q3 2021

Nov 02, 2021

BUY
$109.17 - $142.35 $15,938 - $20,783
146 Added 0.02%
679,775 $90.5 Million
Q2 2021

Aug 02, 2021

BUY
$100.34 - $115.69 $291,788 - $336,426
2,908 Added 0.43%
679,629 $73.5 Million
Q1 2021

May 11, 2021

SELL
$101.51 - $125.27 $2.18 Million - $2.69 Million
-21,495 Reduced 3.08%
676,721 $71.3 Million
Q4 2020

Feb 08, 2021

SELL
$85.88 - $105.36 $6.01 Million - $7.38 Million
-70,022 Reduced 9.11%
698,216 $72.7 Million
Q3 2020

Nov 05, 2020

SELL
$72.74 - $92.5 $1.48 Million - $1.88 Million
-20,300 Reduced 2.57%
768,238 $65.8 Million
Q2 2020

Aug 07, 2020

SELL
$48.02 - $79.04 $3.45 Million - $5.68 Million
-71,896 Reduced 8.36%
788,538 $57.8 Million
Q1 2020

May 06, 2020

SELL
$36.95 - $62.95 $176,990 - $301,530
-4,790 Reduced 0.55%
860,434 $44.7 Million
Q4 2019

Feb 05, 2020

SELL
$47.06 - $56.64 $232,005 - $279,235
-4,930 Reduced 0.57%
865,224 $48.7 Million
Q3 2019

Nov 07, 2019

SELL
$47.45 - $58.05 $637,158 - $779,495
-13,428 Reduced 1.52%
870,154 $41.5 Million
Q2 2019

Aug 09, 2019

SELL
$39.26 - $54.21 $340,109 - $469,621
-8,663 Reduced 0.97%
883,582 $47.9 Million
Q1 2019

May 08, 2019

SELL
$29.84 - $43.92 $119,360 - $175,680
-4,000 Reduced 0.45%
892,245 $36.2 Million
Q4 2018

Feb 08, 2019

BUY
$29.95 - $46.34 $488,185 - $755,342
16,300 Added 1.85%
896,245 $27.9 Million
Q3 2018

Nov 07, 2018

SELL
$40.12 - $45.55 $269,726 - $306,232
-6,723 Reduced 0.76%
879,945 $40.1 Million
Q2 2018

Aug 10, 2018

BUY
$38.72 - $42.52 $4.48 Million - $4.92 Million
115,800 Added 15.02%
886,668 $37.1 Million
Q1 2018

May 10, 2018

SELL
$39.4 - $47.39 $52,756 - $63,455
-1,339 Reduced 0.17%
770,868 $31.7 Million
Q4 2017

Feb 13, 2018

SELL
$37.27 - $43.02 $4.22 Million - $4.87 Million
-113,259 Reduced 12.79%
772,207 $31.7 Million
Q3 2017

Nov 06, 2017

BUY
$33.75 - $41.67 $1.2 Million - $1.48 Million
35,583 Added 4.19%
885,466 $35.3 Million
Q2 2017

Aug 11, 2017

BUY
N/A
849,883
849,883 $29.8 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.